NKTX vs RJF · $188.9M cap vs rev $15.91B
Nkarta Inc (NKTX) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Nkarta Inc (NKTX) is a biotechnology company listed on NASDAQ.
RJF (RJF) common stock.
Latest reported NKTX revenue for 2025-12-31 was $0. Net income was -$104.1M. NKTX currently screens at market cap $188.9M.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
NKTX currently screens at market cap $188.9M. RJF currently screens at market cap $0.
Not investment advice. Open the NKTX and RJF stock pages for the full models.
Not investment advice.